In accordance with these tumor weight findings, cell proliferation as assessed by Ki-67 staining was reduced following treatment with AZA1 (p<0.05) (Figure 6D), suggesting an anti-proliferative effect of Rho GTPase inhibition by the compound AZA1. This evidence concerns the gene MKI67 and neoplasm.